Femoston 2mg/10 mg film-coated tablets
*Company:
Theramex Ireland LimitedStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 03 December 2025
File name
Femoston_2mg.10mg_IRISH_SMPC.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 03 December 2025
File name
Femoston 2mg_10mg Ireland PIL.pdf
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 6 - date of revision
Updated on 24 November 2025
File name
Femoston_2mg.10mg_IRISH_SMPC.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 24 November 2025
File name
Femoston 2mg_10mg Ireland PIL.pdf
Reasons for updating
- New PIL for new product
Theramex Ireland Limited
Address:
Theramex HQ UK Ltd, 50 Broadway, 5th Floor, London SW1H 0BL, UKMedical Information E-mail:
Medinfo.ie@theramex.comTelephone:
+44 (0) 20 3962 5555Medical Information Direct Line:
01 903 6075